Innovation

Biotechnology Innovation

Taking validated biotechnology — platforms, devices and biomaterials — from a working method to something deployable.

The gap

Validated is not the same as deployable

A method that has been validated in a research laboratory has cleared a scientific bar. It has not yet cleared the practical ones: can it be manufactured consistently, transported without a cold chain, run by a technician after a short training, supplied with reagents that are actually obtainable, and priced within reach of the intended user?

Each of those can end a project after the science has succeeded. Our biotechnology innovation work addresses them deliberately, and does so early — because a design decision taken during development is far cheaper to change than one discovered at deployment.

Focus areas

What we work on

Diagnostic platforms

Systems designed around the conditions of the laboratories that would actually run them.

Devices

Instrumentation and consumables specified for durability, serviceability and realistic operating conditions.

Biomaterials

Materials characterised and tested against the application, with supply and cost considered from the outset.

Reagent simplification

Reducing dependence on scarce, expensive or cold-chain-dependent reagents.

Manufacturability

Establishing whether something can be produced consistently at the scale required.

Technology transfer

Documenting protocols so other laboratories can adopt a method, and supporting them while they do.

The research behind it

Innovation work builds on the Center's biotechnology research, where methods are developed and validated before any question of deployment arises.

Biotechnology research

Develop a biotechnology with us

We welcome approaches from researchers with a validated method, and from manufacturers interested in producing accessible health technologies.

Discuss a project Submit an idea